Abstract
Nanoparticles (NPs) formulated using poly (d,l-lactide-co-glycolide) (PLGA), a biodegradable, biocompatible, and clinically approved polymer, have been widely used for targeted drug delivery. Here we provide methods for preparing PLGA NPs that encapsulate small interfering RNA (siRNA). The siRNA NPs are formulated using a double-emulsion solvent evaporation technique with the addition of a small amount of the cationic polymer, polyethyleneimine, which significantly increases siRNA encapsulation.
| Original language | English (US) |
|---|---|
| Title of host publication | Nanoparticles in Biology and Medicine |
| Subtitle of host publication | Methods and Protocols |
| Editors | Mikhail Soloviev |
| Pages | 311-319 |
| Number of pages | 9 |
| DOIs | |
| State | Published - 2012 |
Publication series
| Name | Methods in Molecular Biology |
|---|---|
| Volume | 906 |
| ISSN (Print) | 1064-3745 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cancer therapy
- Cancer treatment
- Drug delivery
- Nanoparticles
- Poly(lactic-co-glycolic) acid
- RNAi
- siRNA
Fingerprint
Dive into the research topics of 'Preparation of sirna-encapsulated plga nanoparticles for sustained release of sirna and evaluation of encapsulation efficiency'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS